New study seeks immune clues to prevent HCMV transmission in pregnancy

NCT ID NCT07477925

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is looking for immune system markers that might predict whether a pregnant woman with a first-time HCMV infection will pass the virus to her unborn baby. Researchers will study blood samples from 90 pregnant women and their newborns to see which immune responses are linked to lower transmission risk. The goal is to develop a test that helps doctors better assess risk and guide care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HUMAN CYTOMEGALOVIRUS (HCMV) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fondazione IRCCS Policlinico San Matteo

    RECRUITING

    Pavia, Lombardy, 27100, Italy